Savings Alert: We've added new, lower prices at most pharmacies for this prescription. Learn More
The GoodRx Pharmacist - April 18, 2017
If you have ever experienced a serious reaction to a medication, you are not alone. In 2000, the Institute of Medicine reported that more than 2 million serious adverse drug reactions occur each year. The FDA keeps track of these serious events through a reporting system and releases them quarterly. This system, the FDA Adverse Event Reporting System (FAERS), is a database that contains information on adverse events and medication error reports that have been submitted. See More
The GoodRx Pharmacist - February 25, 2017
Americans’ use of supplements, prescriptions and over the counter (OTC) medications has been steadily increasing over the past couple of years. This increase can sometimes put patients at risk for complications and interactions. Believe it or not, a lot of over-the-counter medications can actually interact with your prescription medications (and affect how they work) without you even realizing it. See More
Elizabeth Davis - August 17, 2016
Americans, get ready for sticker shock at the pharmacy.
In 2017, the nation’s largest insurance companies will likely exclude up to 154 different drugs from coverage. If you’re taking one of these prescriptions, your co-pay is about to go way, way up.
Last year, popular drugs including Viagra and Qsymia were dropped by major insurance plans for 2016. The trend continues this year. Almost 50 popular brand-name and generic drugs will likely no longer be covered by one of the nation’s largest prescription insurance providers. See More
The GoodRx Pharmacist - March 24, 2015
When you pick up your medications at the pharmacy you may notice that they are typically dispensed in amber colored vials or plastic containers. You may or may not be aware that these amber colored vials are not the original bottle the manufacturer dispensed the medication in.
For the majority of medications, transferring them from the manufacturer’s original bottle to the pharmacy’s amber vials is not a big deal, and lets the pharmacy purchase in bulk (which is more cost-effective)—unless you are taking certain medications. See More
Dr. Sharon Orrange - September 03, 2014
Doctors treating patients with atrial fibrillation have embraced the new oral anticoagulants and more than 60% of new prescriptions are now written for the newer choices instead of warfarin (Coumadin). Xarelto seems to be gaining speed as the dominating new blood thinner. Xarelto use has increased quickly, with more patients being treated with this drug than with warfarin or Pradaxa in 2013.
Here are 10 things you need to know about Xarelto:
1. See More
Dr. Sharon Orrange - April 02, 2014
Almost 6 million Americans have the irregular heart rhythm atrial fibrillation. Atrial fib increases your risk of stroke, heart failure, dementia, and early mortality. New guidelines have just been released, with some pretty big changes on how to manage atrial fib. Here is what you need to know:
1. Know the score.
The decision of whether or not you need to be on blood thinners when you have atrial fib has always been based on your score. See More
Dr. Sharon Orrange - February 12, 2014
Coumadin (warfarin) has been the mainstay of treatment for stroke prevention in folks with atrial fibrillation. When the atrium is fibrillating, and losing its atrial kick, there is a higher risk of clot forming in the atrium which will break off into the ventricle, then head to your brain and cause a stroke.
For that reason, we treat some folks with atrial fibrillation with blood thinners to prevent that stroke risk. See More
Dr. Sharon Orrange - December 19, 2013
The newer anticoagulants like Xarelto (rivaroxaban), known as Factor Xa inhibitors, save you from repeated blood tests for INR checks that you will need while on Coumadin (warfarin). Many folks wonder how they can change from Coumadin to the newer medications.
First, who can use Xarelto? Xarelto is a pill approved for use in folks with a known clot in their leg (deep venous thrombosis or DVT), a clot in their lung (pulmonary embolism or PE), prevention of clot/stroke in people with atrial fibrillation who do NOT have valve disease, and to decrease the risk of forming a clot in your leg or lung after hip or knee replacement surgery. See More
Dr. Sharon Orrange - January 04, 2013
Of all the new oral anticoagulants set to take over for Coumadin (warfarin) the new drug Xarelto just scored a trifecta. Remember these newer blood thinners are much more convenient than warfarin because you are spared the weekly blood tests to monitor your INR (coagulation levels).
Xarelto (rivaroxaban) has been approved by the FDA for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and to reduce the risk of recurrence of DVT and PE after initial treatment. See More
Dr. Sharon Orrange - November 20, 2012
The buzz around Pradaxa has deflated a bit with reports of bleeding risks. Pradaxa (dabigatran) changes the body’s clotting system and thins the blood to prevent clots from forming. Pradaxa is exciting because it is a good alternative to warfarin in patients with atrial fibrillation. Warfarin (Coumadin), unlike Pradaxa, requires serial blood tests to check INR. Pradaxa is much more convenient than warfarin, but is it riskier?